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Abstract The mammalian target of rapamycin (mTOR) pro-
motes increased protein synthesis required for cell growth. It has
been suggested that phosphatidic acid, produced upon activation
of phospholipase D (PLD), is a common mediator of growth
factor activation of mTOR signaling. We used Rat-1 ¢broblasts
expressing the K1A adrenergic receptor to study if this Gq-
coupled receptor uses PLD to regulate mTOR signaling. Phe-
nylephrine (PE) stimulation of the K1A adrenergic receptor in-
duced mTOR autophosphorylation at Ser2481 and phosphory-
lation of two mTOR e¡ectors, 4E-BP1 and p70 S6 kinase.
These PE-induced phosphorylations were greatly reduced in
cells depleted of intracellular Ca2+. PE activation of PLD
was also inhibited in Ca2+-depleted cells. Incubation of cells
with 1-butanol to inhibit PLD signaling attenuated PE-induced
phosphorylation of mTOR, 4E-BP1 and p70 S6 kinase. By
contrast, platelet-derived growth factor (PDGF)-induced phos-
phorylation of these proteins was not blocked by Ca2+ depletion
or 1-butanol treatment. These results suggest that the K1A ad-
renergic receptor promotes mTOR signaling via a pathway that
requires an increase in intracellular Ca2+ and activation of
PLD. The PDGF receptor, by contrast, appears to activate
mTOR by a distinct pathway that does not require Ca2+ or
PLD.
7 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Activation of protein synthesis by growth factors is a com-
plex process that involves phosphorylation of a number of
components of the translational machinery. 4E-BP1 is a trans-
lation repressor that, when hypophosphorylated, binds to
translation initiation factor eIF4E and prevents formation
of a functional eIF4F complex. Treatment of cells with
growth factors leads to the multiple phosphorylation of 4E-
BP1 and its dissociation from eIF4E, thereby relieving the
translational block [1]. Phosphorylation of the S6 protein in
40S ribosomal subunits is also associated with growth factor-
induced activation of protein synthesis. The major kinase that
phosphorylates S6 is p70 S6 kinase, which is activated by
phosphorylation at multiple sites in response to growth factor
treatment [2].
In many systems, growth factor-induced phosphorylation of
4E-BP1 and p70 S6 kinase is blocked by phosphatidylinositol
(PI) 3-kinase inhibitors such as wortmannin and LY294002
and by the immunosuppressant rapamycin. Rapamycin, when
bound to its intracellular receptor FKBP12, inhibits the func-
tion of the mammalian target of rapamycin (mTOR), a kinase
whose catalytic domain resembles that of PI 3-kinase [3].
mTOR has been shown to phosphorylate 4E-BP1 and p70
S6 kinase at functionally important sites in vitro [4,5] and
to undergo autophosphorylation at Ser2481 [6]. Signaling
through mTOR is thought to be sensitive to nutrient levels
and to the intracellular concentration of ATP [7^9].
Phosphorylation of 4E-BP1 and p70 S6 kinase has been
proposed to be regulated by two parallel pathways that inte-
grate growth factor signaling and nutrient sensing. Mitogen-
activated signals are thought to be transduced through a PI 3-
kinase-dependent pathway, while mTOR is thought to pro-
vide a permissive signal in the presence of su⁄cient nutrients
that allows 4E-BP1 and p70 S6 kinase to respond to the PI 3-
kinase signal [3]. Other models propose that mTOR itself is
regulated by growth factor-generated PI 3-kinase signals [10].
In addition, it was recently proposed that phosphatidic acid,
produced in response to growth factor activation of phospho-
lipase D (PLD), binds to mTOR and is required for mTOR
signaling to 4E-BP1 and p70 S6 kinase [11,12].
Pathological stimulation of K1 adrenergic receptors by cat-
echolamines plays an important role in the development of
cardiac hypertrophy that can lead to heart failure [13]. In-
creased protein synthesis is required for cells to undergo hy-
pertrophic growth. Since all three K1 adrenergic receptors
(K1A; K1B, and K1D) are present in cardiac myocytes, we
have utilized Rat-1 ¢broblasts that stably express the K1A ad-
renergic receptor to investigate how this receptor controls
protein synthesis. We previously demonstrated that activation
of the K1A adrenergic receptor in these cells stimulates protein
synthesis and induces 4E-BP1 phosphorylation and p70 S6
kinase activation [14]. However, unlike some growth factors
such as platelet-derived growth factor (PDGF), K1A adrener-
gic receptor signaling to 4E-BP1 and p70 S6 kinase does not
require activation of PI 3-kinase [15], but is instead mediated
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by a Ca2þ-dependent pathway [14]. In the course of studying
this Ca2þ-dependent pathway, we found that there are distinct
di¡erences in the mechanisms used by the K1A adrenergic
receptor and the PDGF receptor to regulate mTOR signaling.
We determined that stimulation of both receptors a¡ects the
activity of mTOR, as re£ected by autophosphorylation of
Ser2481. We next evaluated whether Ca2þ and PLD play a
role in mediating this e¡ect. Our ¢ndings suggest that stimu-
lation of mTOR signaling by the K1A adrenergic receptor, but
not the PDGF receptor, requires an increase in intracellular
Ca2þ and activation of PLD.
2. Materials and methods
2.1. Materials
Phenylephrine, PDGF A/B, 1-butanol, BAPTA-AM and A23187
were from Sigma (St. Louis, MO, USA). [3H]Palmitic acid (30^60
Ci/mmol) was from American Radiolabeled Chemicals (St. Louis,
MO, USA). Rapamycin, LY294002 and phorbol 12-myristate 13-ace-
tate (PMA) were from Calbiochem (San Diego, CA, USA). Phospho-
speci¢c antibodies and antibody to total mTOR were from Cell Sig-
naling Technology (Beverly, MA, USA). Antibodies to total 4E-BP1
and total p70 S6 kinase were from Santa Cruz Biotechnology (Santa
Cruz, CA, USA).
2.2. Cell culture
Rat-1 ¢broblasts stably transfected with the human K1A adrenergic
receptor [16] were maintained in Dulbecco’s modi¢ed Eagle’s medium
(Mediatech, Herndon, VA, USA) containing antibiotics and 10% fetal
bovine serum (Sigma). Cells were incubated in serum-free medium for
16^18 h before treatments. For experiments involving Ca2þ, cells were
preincubated for 1 h in high-salt glucose bu¡er (10 mM HEPES, pH
7.4, 140 mM NaCl, 4 mM KCl, 2 mM MgSO4, 1 mM KH2PO4 and
10 mM glucose) plus either 2 mM EGTA or 1 mM Ca2þ before
adding agonist to the bu¡er.
2.3. Immunoblotting
Cell lysates were prepared in bu¡er containing 50 mM HEPES, pH
7.5, 1% Triton X-100, 50 mM NaCl, 5 mM EDTA, 50 mM NaF, 10
mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM
phenylmethylsulfonyl £uoride, and 10 Wg/ml each of aprotinin and
leupeptin. Proteins were subjected to SDS gel electrophoresis and
Western blotting as previously described [15]. The integrated density
of bands was quanti¢ed using Scion Image Beta 4.0.2. The numerical
values under the Western blots represent a ratio obtained by dividing
the integrated density of bands in the upper panels by that of the
corresponding bands in the lower panels.
2.4. PLD assay
Cells were labeled with 2 WCi/ml of [3H]palmitic acid in growth
medium for 48 h. The labeling medium was replaced with either se-
rum-free medium or high-salt glucose bu¡er 1 h prior to agonist
treatments. 0.3% 1-butanol was added just before the agonist. The
cells were extracted with methanol and [3H]phosphatidylbutanol was
measured as previously described [17].
3. Results and discussion
3.1. K1A adrenergic receptor stimulation promotes mTOR
autophosphorylation
Although growth factors can cause large increases in 4E-
BP1 phosphorylation and p70 S6 kinase activity, increases in
mTOR kinase activity measured in vitro are usually relatively
small. Phosphorylation of Ser2481 in wild-type mTOR, but
not a kinase-dead mutant, was readily detected in cells, sug-
gesting that Ser2481 is an autophosphorylation site that can
serve as a reporter of in vivo mTOR kinase activity [6]. We
therefore used a phospho-speci¢c antibody and Western blot-
ting to assess changes in mTOR Ser2481 phosphorylation
after exposing Rat-1 cells to phenylephrine (PE), an K1A ad-
renergic receptor agonist. mTOR in serum-starved cells exhib-
ited a basal level of Ser2481 phosphorylation (Fig. 1A, top
blot). Stimulation of the K1A adrenergic receptor led to an
increase in phosphorylation that was nearly maximal at 10
min and persisted up to 30 min. A comparable increase in
Ser2481 phosphorylation was seen after serum stimulation
of human embryonic kidney (HEK) 293 cells [6]. The mem-
brane was reprobed with a general mTOR antibody to con-
¢rm that similar amounts of the protein were present in each
lane (Fig. 1A, bottom blot).
In a prior study, we showed that rapamycin and LY294002
interfere with K1A adrenergic receptor signaling to 4E-BP1
and p70 S6 kinase [14]. The e¡ect of these two inhibitors on
K1A adrenergic receptor-induced mTOR phosphorylation was
examined by incubating serum-starved cells with rapamycin or
LY294002 prior to stimulation with PE. PE-induced phos-
phorylation of mTOR at Ser2481 was attenuated in the pres-
ence of rapamycin (Fig. 1B, top blot). LY294002 was an even
more e¡ective inhibitor of mTOR phosphorylation: the basal
phosphorylation of Ser2481 was reduced to an undetectable
level, and mTOR autophosphorylation in response to PE
treatment was almost completely blocked (Fig. 1B, top blot).
In contrast to our results, Peterson et al. detected no sig-
ni¢cant change in Ser2481 phosphorylation after treatment of
cells with rapamycin [6]. This discrepancy might be due to
di¡erences in the order of addition of drug and agonist: in
Ref. [6] rapamycin was added to cells that were already grow-
ing in serum, whereas we added the drug to serum-starved
cells prior to stimulation with agonist. It is possible that ra-
pamycin does not e¡ectively reverse Ser2481 phosphorylation,
but is e¡ective at preventing agonist-induced mTOR auto-
phosphorylation. Similar to our results using LY294002,
Fig. 1. PE-induced mTOR phosphorylation is blocked by rapamycin
and LY294002. A: Cells were treated with 10 WM PE for the indi-
cated times. Equal amounts of cell lysate protein were analyzed on
a Western blot probed sequentially with antibodies to phospho-
Ser2481 mTOR (top blot) and total mTOR (lower blot). B: Cells
were pretreated for 30 min with vehicle, 20 nM rapamycin or 50
WM LY294002, followed by stimulation with or without 10 WM PE
for 20 min. Cell lysate proteins were analyzed on a Western blot
probed sequentially with antibodies to phospho-Ser2481 mTOR (top
blot) and total mTOR (lower blot). The experiments were done at
least three times and representative results are shown.
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wortmannin was also reported to signi¢cantly inhibit mTOR
Ser2481 autophosphorylation [6]. Although LY294002 and
wortmannin are best known as PI 3-kinase inhibitors, these
two compounds have also been shown to inhibit mTOR ki-
nase activity [18]. PE treatment of Rat-1 cells does not acti-
vate PI 3-kinase [15], so the inhibitory e¡ect of LY294002 on
mTOR phosphorylation in response to PE treatment is pre-
sumably due to a direct e¡ect on mTOR and not to PI 3-ki-
nase inhibition.
3.2. PE-induced mTOR phosphorylation is Ca2+-dependent
Like all Gq-coupled receptors, stimulation of the K1A ad-
renergic receptor leads to an increase in the intracellular Ca2þ
concentration ([Ca2þ]i) [15]. We reported that pretreatment of
Rat-1 cells with BAPTA-AM to chelate intracellular Ca2þ
inhibits PE-induced 4E-BP1 phosphorylation and p70 S6 ki-
nase activation [14]. In addition, raising the [Ca2þ]i with the
Ca2þ ionophore A23187 increased the phosphorylation of 4E-
BP1 and activated p70 S6 kinase [14]. To examine the role of
Ca2þ in K1A adrenergic receptor signaling to mTOR, serum-
starved cells were preincubated with or without BAPTA-AM
prior to stimulation with PE. BAPTA-AM strongly inhibited
PE-induced mTOR phosphorylation (Fig. 2A, top blot). In
addition, raising the [Ca2þ]i with A23187 stimulated mTOR
phosphorylation as much as PE treatment did (Fig. 2A, top
blot).
Treatment of Rat-1 cells with PDGF, unlike PE, causes a
substantial increase in PI 3-kinase activity [15]. PDGF also
stimulates 4E-BP1 phosphorylation and p70 S6 kinase activa-
tion in a rapamycin-sensitive manner, indicating a require-
ment for mTOR [14]. We asked whether the PDGF receptor
also requires Ca2þ to stimulate mTOR signaling. Rat-1 cells
were treated with PE or PDGF in bu¡er containing either
Ca2þ or EGTA; the latter condition has been shown to com-
pletely abolish the PE-induced increase in [Ca2þ]i [15]. In the
presence of Ca2þ, both PE and PDGF induced a robust in-
crease in mTOR phosphorylation, although the e¡ect with
PDGF was stronger (Fig. 2B, top panel). Interestingly, PE-
induced Ser2481 phosphorylation was strongly inhibited in
the presence of EGTA, whereas the response to PDGF was
largely una¡ected by Ca2þ depletion (Fig. 2B, top blot). To-
gether, these results suggest that a rise in [Ca2þ]i is required
for PE-induced, but not PDGF-induced, mTOR phosphory-
lation. In addition, high [Ca2þ]i alone is su⁄cient to trigger
mTOR Ser2481 phosphorylation.
Using phospho-speci¢c antibodies and Western blotting, we
also compared the Ca2þ dependence of phosphorylation of
4E-BP1 and p70 S6 kinase in response to PE and PDGF.
mTOR has been shown to directly phosphorylate p70 S6 ki-
nase at Thr389 [5] and to promote 4E-BP1 phosphorylation at
Ser64 [19]. In the presence of Ca2þ, treatment with either PE
or PDGF stimulated the phosphorylation of 4E-BP1 (Fig. 2C,
top blot) and p70 S6 kinase (Fig. 2C, third blot). Similar to
what was seen with mTOR autophosphorylation, PDGF
evoked stronger responses than PE. In addition, PE-induced
phosphorylation of Ser64 4E-BP1 and Thr389 p70 S6 kinase
was strongly inhibited in the presence of EGTA, whereas the
e¡ect of PDGF was still intact in Ca2þ-depleted cells (Fig. 2C,
top and third blots). The membranes were reprobed for total
4E-BP1 (Fig. 2C, second blot) and p70 S6 kinase (Fig. 2C,
bottom blot) to demonstrate that each lane contained similar
amounts of each protein. These results indicate that autophos-
Fig. 2. E¡ect of [Ca2þ]i on PE-induced phosphorylation of mTOR,
4E-BP1 and p70 S6 kinase. A: Cells were pretreated for 30 min
with 10 WM BAPTA-AM or vehicle and then stimulated for 20 min
with or without 10 WM PE. In the right lane, cells were treated with
10 WM A23187 for 20 min. Phospho-Ser2481 mTOR (top blot) and
total mTOR (lower blot) were detected on a Western blot. B: Cells
were preincubated in high-salt glucose bu¡er with EGTA or Ca2þ
(see Section 2.2), then stimulated for 20 min with or without 10 WM
PE or 25 ng/ml PDGF. Equal amounts of cell lysate protein were
analyzed on a Western blot probed sequentially with antibodies to
phospho-Ser2481 mTOR (top blot) and total mTOR (bottom blot).
C: Cells were treated as in B. Cell lysate proteins were analyzed on
Western blots to detect phospho-Ser64 4E-BP1 (numbering is based
on the sequence of the rat protein) and total 4E-BP1 (top two
blots), and phospho-Thr389 p70 S6 kinase and total p70 S6 kinase
(bottom two blots). Total 4E-BP1 appears as multiple bands due to
migration di¡erences of di¡erentially phosphorylated species. D:
Cells were preincubated in serum-free medium with or without 100
nM PMA for 24 h, followed by treatment with or without 10 WM
PE or 100 nM PMA for 20 min. Phospho-Ser2481 mTOR (top
blot) and total mTOR (lower blot) were detected on a Western
blot. The experiments were done three times and representative re-
sults are shown.
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phorylation of mTOR and mTOR signaling to downstream
e¡ectors in response to K1A adrenergic receptor stimulation is
Ca2þ-dependent. PDGF apparently uses a di¡erent mecha-
nism to activate mTOR signaling that does not require an
increase in [Ca2þ]i.
3.3. PE-induced mTOR phosphorylation is not dependent on
PKC
The increase in [Ca2þ]i and production of diacylglycerol
following stimulation of Gq-coupled receptors leads to activa-
tion of Ca2þ- and diacylglycerol-dependent isoforms of pro-
tein kinase C (PKC) [13]. We investigated the role of these
enzymes in K1A adrenergic receptor-mediated phosphorylation
of mTOR by treating cells with or without PMA for 24 h to
down-regulate PKCs prior to challenge with an agonist.
Treatment of control cells with either PE or PMA for 20
min induced the phosphorylation of Ser2481 mTOR (Fig.
2D, upper blot). In cells pretreated for 24 h with PMA, phos-
phorylation of mTOR by a subsequent challenge with PMA
was abolished, but there was no e¡ect on PE-induced phos-
phorylation of the protein (Fig. 2D, upper blot). Thus, phos-
phorylation of mTOR promoted by the K1A adrenergic recep-
tor does not require PMA-sensitive PKCs. This result is
consistent with our observations that PE stimulation of 4E-
BP1 phosphorylation [14] and p70 S6 kinase activation [15] is
also independent of PMA-sensitive PKCs.
3.4. PE activation of PLD is Ca2+-dependent
It is well known that increases in [Ca2þ]i in response to
hormone stimulation or ionophore treatment can lead to ac-
tivation of PLD [20]. Using an in vivo assay, we ¢rst tested if
treatment of cells with agonists in serum-free medium in-
creases PLD activity. PE treatment activated PLD approxi-
mately 10-fold (Fig. 3A). This response was comparable to
that achieved using PMA, which is one of the most potent
PLD activators known (data not shown). In contrast, PDGF
treatment stimulated PLD activity only about three-fold (Fig.
3A).
We next examined whether the PE-induced increase in PLD
activity is dependent on [Ca2þ]i. PE treatment of cells in Ca2þ-
containing bu¡er stimulated PLD activity approximately four-
fold, whereas Ca2þ depletion with EGTA completely abol-
Fig. 3. E¡ect of LY294002 and [Ca2þ]i on PE-induced PLD activa-
tion. Cells were labeled with [3H]palmitate in normal growth me-
dium for 48 h. After treatments, cells were extracted with methanol
and [3H]phosphatidylbutanol levels were measured (see Section 2.4).
A: Labeled cells were placed into serum-free medium for 30 min,
and then were incubated for 30 min with or without 50 WM
LY294002. Then the cells were stimulated for 20 min with or with-
out 10 WM PE or 25 ng/ml PDGF. Data shown are meansS stan-
dard error (n=5 for Control and PE; n=3 for LY/PE and PDGF).
B: Labeled cells were incubated for 1 h in high-salt glucose bu¡er
with Ca2þ or EGTA (see Section 2.2), then stimulated for 20 min
with or without 10 WM PE. Data shown are meansS standard error
(n=4).
Fig. 4. E¡ect of 1-butanol on PE-induced phosphorylation of
mTOR, 4E-BP1 and p70 S6 kinase. Serum-starved cells were prein-
cubated with or without 0.3% 1-butanol for 30 min, then stimulated
for 20 min with 10 WM PE or 25 ng/ml PDGF. A: Equal amounts
of cell lysate protein were analyzed on a Western blot probed se-
quentially with antibodies to phospho-Ser2481 mTOR (top blot)
and total mTOR (bottom blot). B: Cell lysate proteins were ana-
lyzed on Western blots to detect phospho-Ser64 4E-BP1 and total
4E-BP1 (top two blots), and phospho-Thr389 p70 S6 kinase and to-
tal p70 S6 kinase (bottom two blots). Total 4E-BP1 and total p70
S6 kinase appear as multiple bands due to migration di¡erences of
di¡erentially phosphorylated species. The experiment was done three
times with similar results.
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ished this response (Fig. 3B). Malik and coworkers reported a
similar result using this cell system [21]. In addition, these
authors found that PE activation of PLD is independent of
PKC [21]. Together, these results indicate that PE activation
of PLD, like mTOR autophosphorylation, is Ca2þ-dependent
but PKC-independent.
3.5. 1-Butanol inhibits PE-stimulated mTOR phosphorylation
Phosphatidic acid, a lipid second messenger produced by
PLD, has been proposed to be a critical component for
mTOR signaling [11]. PE-induced PLD activation was not
blocked in cells pretreated with LY294002 (Fig. 3A), suggest-
ing that PLD might indeed act upstream of mTOR, but not
vice versa. To test the hypothesis that PLD and mTOR act in
a common signaling pathway, cells were pretreated with 1-bu-
tanol prior to stimulation with agonist. Through a transphos-
phatidylation reaction, 1-butanol prevents the production of
phosphatidic acid. PE-induced Ser2481 mTOR phosphoryla-
tion was completely blocked in the presence of 1-butanol,
whereas the PDGF-stimulated increase was largely una¡ected
(Fig. 4A, top blot). Likewise, pretreatment with 1-butanol
blocked PE-induced phosphorylation of Ser64 on 4E-BP1
(Fig. 4B, top blot) and Thr389 on p70 S6 kinase (Fig. 4B,
third blot), but increased phosphorylation at these sites in
response to PDGF was still intact.
3.6. Two distinct pathways control mTOR signaling
Chen and coworkers recently reported that serum treatment
of HEK 293 cells led to the PLD-dependent accumulation of
phosphatidic acid, which was required for 4E-BP1 phosphor-
ylation and p70 S6 kinase activation [11]. They speculated
that this might be a common pathway used by mitogens to
activate mTOR signaling [11,12]. However, the data presented
here suggest that PLD activation is used by only a subset of
growth factors to regulate the mTOR pathway.
Our data indicate that PE stimulation of the K1A adrenergic
receptor activates a signaling pathway that includes an in-
crease in [Ca2þ]i, activation of PLD, autophosphorylation of
mTOR, and phosphorylation of the mTOR e¡ectors 4E-BP1
and p70 S6 kinase (Fig. 5). These results support the conclu-
sion of Chen and coworkers [11] that PLD can regulate
mTOR. We speculate that G protein-coupled receptors that
mobilize intracellular Ca2þ but do not activate PI 3-kinase
might require the PLD-dependent mechanism to regulate
mTOR. A selective requirement for PLD to activate mTOR
signaling by G protein-coupled receptors might allow develop-
ment of drugs to selectively block pathological activation of
mTOR by this receptor family.
By contrast, even though the PDGF receptor activates
PLD, it appears to use a distinct pathway that does not re-
quire an increase in [Ca2þ]i or PLD activity to activate mTOR
signaling. One possibility is that this receptor also activates
diacylglycerol kinase to produce phosphatidic acid; this reac-
tion would not be inhibited by 1-butanol. Alternatively, the
PDGF receptor, and perhaps other tyrosine kinase receptors,
might require the activation of PI 3-kinase to stimulate
mTOR signaling (Fig. 5). Recent data suggest that PI 3-kinase
and its downstream e¡ector, the protein kinase Akt, control
mTOR through the TSC1-TSC2 tumor suppressor complex
[10]. According to a model based on these data, in the absence
of growth factors the TSC1^TSC2 complex is hypophos-
phorylated and inhibits mTOR. Growth factor activation of
PI 3-kinase/Akt results in the phosphorylation and inhibition
of TSC1-TSC2, leading to derepression of mTOR, which can
then phosphorylate 4E-BP1 and p70 S6 kinase [10]. In addi-
tion to a direct e¡ect of phosphatidic acid on mTOR [11], one
might imagine that mTOR activation by the K1A adrenergic
receptor would also require inhibition of TSC1^TSC2. If so,
the kinase that phosphorylates TSC1-TSC2 would be distinct
from Akt, since the K1A adrenergic receptor does not activate
Akt [15]. Indeed, we have found that treatment of Rat-1 cells
with PE does not induce the phosphorylation of TSC2 at
Thr1462, whereas PDGF causes an increase in phosphoryla-
tion at this site (data not shown). Thr1462 on TSC2 is
thought to be a functionally important Akt phosphorylation
site [10]. Future experiments are aimed at testing whether
agonists that regulate mTOR by the PLD pathway promote
phosphorylation of TSC1^TSC2 at other sites that regulate
the function of the complex.
Acknowledgements: This work was supported by NIH R01 DK62722
and by a Department of Veterans A¡airs Medical Research merit
review grant (to R.Z.L.).
References
[1] Raught, B., Gingras, A.C. and Sonenberg, N. (2000) in: Trans-
lational Control of Gene Expression (Sonenberg, N., Hershey,
J.W.B. and Mathews, M.B., Eds.), pp. 245^293, Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, NY.
[2] Fumagalli, S. and Thomas, G. (2000) in: Translational Control
of Gene Expression (Sonenberg, N., Hershey, J.W.B. and Math-
ews, M.B., Eds.), pp. 695^717, Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, NY.
[3] Gingras, A.C., Raught, B. and Sonenberg, N. (2001) Genes Dev.
15, 807^826.
[4] Brunn, G.J., Hudson, C.C., Sekulic, A., Williams, J.M., Hosoi,
H., Houghton, P.J., Lawrence Jr., J.C. and Abraham, R.T.
(1997) Science 277, 99^101.
[5] Isotani, S., Hara, K., Tokunaga, C., Inoue, H., Avruch, J. and
Yonezawa, K. (1999) J. Biol. Chem. 274, 34493^34498.
[6] Peterson, R.T., Beal, P.A., Comb, M.J. and Schreiber, S.L.
(2000) J. Biol. Chem. 275, 7416^7423.
[7] Kimball, S.R. and Je¡erson, L.S. (2000) in: Translational Con-
trol of Gene Expression (Sonenberg, N., Hershey, J.W.B. and
Fig. 5. Model for two pathways regulating mTOR. The K1A adren-
ergic receptor (K1A-AR) activates a pathway that requires an in-
crease in [Ca2þ]i, activation of PLD, and accumulation of phospha-
tidic acid (PA) to induce mTOR activation and phosphorylation of
4E-BP1 and p70 S6 kinase (p70S6K). The PDGF receptor
(PDGFR) activates PI 3-kinase (PI3K) and Akt, which phosphory-
lates TSC1^TSC2 to activate mTOR signaling [10].
FEBS 27528 13-8-03
L.M. Ballou et al./FEBS Letters 550 (2003) 51^56 55
Mathews, M.B., Eds.), pp. 561^579, Cold Spring Harbor Labo-
ratory Press, Cold Spring Harbor, NY.
[8] Dennis, P.B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S.C.
and Thomas, G. (2001) Science 294, 1102^1105.
[9] Kim, D.H., Sarbassov, D.D., Ali, S.M., King, J.E., Latek, R.R.,
Erdjument-Bromage, H., Tempst, P. and Sabatini, D.M. (2002)
Cell 110, 163^175.
[10] Marygold, S.J. and Leevers, S.J. (2002) Curr. Biol. 12, R785^
R787.
[11] Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. and
Chen, J. (2001) Science 294, 1942^1945.
[12] Chen, J. and Fang, Y. (2002) Biochem. Pharmacol. 64, 1071^
1077.
[13] Schluter, K.D. and Piper, H.M. (1999) FASEB J. 13, S17^S22.
[14] Rybkin, I.I., Cross, M.E., McReynolds, E.M., Lin, R.Z. and
Ballou, L.M. (2000) J. Biol. Chem. 275, 5460^5465.
[15] Ballou, L.M., Cross, M.E., Huang, S., McReynolds, E.M.,
Zhang, B.X. and Lin, R.Z. (2000) J. Biol. Chem. 275, 4803^4809.
[16] Kenny, B.A., Miller, A.M., Williamson, I.J., O’Connell, J.,
Chalmers, D.H. and Naylor, A.M. (1996) Br. J. Pharmacol.
118, 871^878.
[17] Frohman, M.A., Kanaho, Y., Zhang, Y. and Morris, A.J. (2000)
Methods Enzymol. 325, 177^189.
[18] Brunn, G.J., Williams, J., Sabers, C., Wiederrecht, G., Lawrence
Jr., J.C. and Abraham, R.T. (1996) EMBO J. 15, 5256^5267.
[19] Gingras, A.C., Gygi, S.P., Raught, B., Polakiewicz, R.D., Abra-
ham, R.T., Hoekstra, M.F., Aebersold, R. and Sonenberg, N.
(1999) Genes Dev. 13, 1422^1437.
[20] Exton, J.H. (1999) Biochim. Biophys. Acta 1439, 121^133.
[21] Parmentier, J.H., Ahmed, A., Ruan, Y., Gandhi, G.K., Saeed,
A.E. and Malik, K.U. (2002) J. Pharmacol. Exp. Ther. 303,
1206^1215.
FEBS 27528 13-8-03
L.M. Ballou et al./FEBS Letters 550 (2003) 51^5656
